Oklo (NYSE:OKLO) Posts Quarterly Earnings Results

Oklo (NYSE:OKLO) released its quarterly earnings results on Friday. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.16) by ($0.12), Zacks reports. The firm had revenue of $1.21 million during the quarter, compared to the consensus estimate of $0.09 million. The company’s revenue was up 11900.0% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.18) earnings per share.

Here are the key takeaways from Oklo’s conference call:

• Groves reached first criticality after transitioning from a greenfield site to an operating isotope reactor in just over 11 months, according to management. Oklo said the project validated its construction, authorization, commissioning, and operating capabilities for future deployments.
• Aurora-INL advanced with DOE approval of its preliminary documented safety analysis, site mobilization, and reactor-area excavation nearing completion; the company continues to target a 2028 startup. Oklo also expanded Ohio campus execution planning through an MOU with Kiewit and continued PJM interconnection work.
• Oklo is pursuing a diversified fuel strategy spanning EBR-II material, a potential DOE plutonium allocation, Centrus commercial HALEU, and future recycling. The Centrus letter of intent could support initial core and reload needs for up to five Aurora powerhouses, although it remains subject to a definitive agreement and deliveries are expected from 2029.
• The company strengthened its vertically integrated platform through acquisitions of ARMEC and Creative Engineers, adding engineering, manufacturing, testing, and sodium-systems capabilities. Oklo also highlighted collaborations with NVIDIA, Los Alamos National Laboratory, and DOE initiatives to apply AI to fuel qualification, reactor design, and operational workflows.
• Oklo raised its 2026 guidance for operating cash use to $120 million–$150 million from $80 million–$100 million and property, plant, and equipment spending to $400 million–$500 million from $350 million–$450 million. The company ended the quarter with more than $3 billion in cash and marketable securities, but isotope revenue is not expected to begin meaningfully until potentially early 2027, primarily from the Idaho laboratory rather than Groves.

Oklo Stock Up 14.7%

OKLO traded up $6.19 during trading on Friday, reaching $48.38. The stock had a trading volume of 22,043,558 shares, compared to its average volume of 8,689,262. The firm has a market capitalization of $8.42 billion, a price-to-earnings ratio of -57.59 and a beta of 1.17. Oklo has a 1-year low of $36.61 and a 1-year high of $193.84. The stock has a 50 day moving average of $50.88 and a two-hundred day moving average of $60.58.

Key Headlines Impacting Oklo

Here are the key news stories impacting Oklo this week:

• Positive Sentiment: First quarterly revenue beat expectations. Oklo reported Q2 revenue of $1.21 million, far above the approximately $90,000 consensus estimate and up sharply year over year. The result provided an early indication of potential commercial activity, despite revenue remaining very small. Oklo Publishes Second Quarter 2026 Financial Results and Business Update
• Positive Sentiment: Groves reactor reached first criticality. Oklo’s Groves Isotope Test Reactor in Texas achieved a controlled, self-sustaining chain reaction at low power less than a year after groundbreaking. The DOE-authorized milestone supports initial isotope-production testing and strengthens the company’s technical and execution case for future reactor projects, including potential data-center power applications. Oklo’s Groves Reactor Achieves First Criticality in Under a Year
• Neutral Sentiment: Investors still face a long commercialization timeline. Management and market commentary indicate that meaningful power-generation revenue may not arrive until 2027–2028. Oklo’s substantial cash reserves provide funding for licensing, development and construction, but the stock’s valuation remains dependent on successful regulatory approvals and project execution. Oklo Q2 2026 Earnings Call Transcript
• Negative Sentiment: Quarterly losses were wider than expected. Oklo reported an adjusted loss of $0.28 per share versus the $0.16 consensus estimate, reflecting continued heavy development spending. The company remains unprofitable, making future financing needs and execution particularly important for shareholders. Oklo Quarterly Earnings Results
• Negative Sentiment: Insider selling remains a risk signal. Reported open-market activity over the past six months showed numerous insider sales and no purchases, including substantial sales by co-founders Jacob DeWitte and Caroline Cochran. This may weigh on sentiment, even though sales can also reflect scheduled transactions or diversification. Oklo Stock Opinions on Reactor Criticality Milestone

Insider Buying and Selling

In related news, insider William Carroll Murphy Goodwin sold 10,548 shares of the business’s stock in a transaction that occurred on Wednesday, May 20th. The shares were sold at an average price of $58.04, for a total value of $612,205.92. Following the sale, the insider directly owned 36,175 shares in the company, valued at $2,099,597. The trade was a 22.58% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Jacob Dewitte sold 140,000 shares of Oklo stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $68.29, for a total transaction of $9,560,600.00. Following the completion of the transaction, the chief executive officer owned 538,039 shares in the company, valued at approximately $36,742,683.31. This trade represents a 20.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 483,629 shares of company stock valued at $29,855,608 over the last three months. Company insiders own 12.70% of the company’s stock.

Hedge Funds Weigh In On Oklo

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Silicon Valley Capital Partners acquired a new stake in shares of Oklo during the 4th quarter valued at about $52,000. UMB Bank n.a. acquired a new position in Oklo in the fourth quarter worth approximately $72,000. Greenline Wealth Management LLC acquired a new position in Oklo in the fourth quarter worth approximately $69,000. Intesa Sanpaolo S.p.A. acquired a new stake in Oklo in the fourth quarter valued at approximately $72,000. Finally, Los Angeles Capital Management LLC acquired a new position in shares of Oklo during the 4th quarter worth $49,000. 85.03% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts recently commented on OKLO shares. HSBC initiated coverage on Oklo in a research report on Thursday, April 23rd. They issued a “buy” rating and a $96.00 target price on the stock. Bank of America initiated coverage on Oklo in a research note on Friday, May 22nd. They issued a “buy” rating and a $80.00 price target for the company. Citigroup raised their price target on Oklo from $73.50 to $76.00 and gave the company a “neutral” rating in a report on Thursday, May 14th. Tigress Financial started coverage on shares of Oklo in a research note on Monday, April 27th. They set a “buy” rating and a $130.00 price objective on the stock. Finally, JPMorgan Chase & Co. initiated coverage on shares of Oklo in a report on Monday, May 11th. They issued a “neutral” rating and a $83.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Oklo has a consensus rating of “Moderate Buy” and an average price target of $88.00.

About Oklo

Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.

The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.